Concepedia

Maria Sällemark

MS

Statistics

Publications

6

Citations

260

H-Index

6

Active since

1984

Affiliations

AstraZeneca (Sweden)(Current)

Maria Sällemark is an author at AstraZeneca (Sweden) specializing in neuropharmacology, medicine, and pharmacology.

Top concepts

Publications per year

1984–2001

6

Publications

6

Effects of Remoxipride and some Related New Substituted Salicylamides on Rat Brain Receptors

Håkan Hall, Maria Sällemark, Eva Jerning · Acta Pharmacologica et Toxicologica · 1986 · 101 citations · Full text

Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors

Nina Mohell, Maria Sällemark, Susanne Rosqvist et al. · European Journal of Pharmacology · 1993 · 48 citations

, , +8

Acute Effects of Atypical Antidepressants on Various Receptors in the Rat Brain

Håkan Hall, Maria Sällemark, Ilse Wedel · Acta Pharmacologica et Toxicologica · 1984 · 48 citations

, , +21

Effects of Temperature on the<i>in Vitro</i>Binding of<sup>3</sup>H‐Raclopride to Rat Striatal Dopamine‐D<sub>2</sub>Receptors

Håkan Hall, Ilse Wedel, Maria Sällemark · Pharmacology & Toxicology · 1988 · 27 citations

Effects of Chronic Neuroleptic Treatment on Agonist Affinity States of the Dopamine‐D<sub>2</sub>receptor in the Rat Brain

Håkan Hall, Maria Sällemark · Pharmacology & Toxicology · 1987 · 25 citations

1–5 of 6